Drug Type siRNA |
Synonyms |
Target |
Action inhibitors |
Mechanism PMVK inhibitors(phosphomevalonate kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Non-Small Cell Lung Cancer | Preclinical | South Korea | 27 Nov 2023 | |
| Pancreatic Cancer | Preclinical | South Korea | 27 Nov 2023 |





